A carregar...
Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
Abstract The management of chronic myeloid leukemia (CML) has been revolutionized by the discovery of tyrosine kinase inhibitors (TKIs) against BCR-ABL1 oncogenic fusion protein. Imatinib, the first BCR-ABL1 TKI, was introduced into clinical practice in the early 2000s. In the following years, the s...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Adis, Springer Healthcare
2019-08-01
|
| Colecção: | Oncology and Therapy |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1007/s40487-019-00098-w |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
A carregar...